Dynamics of amino acid metabolism of primary human liver cells in 3D bioreactors

被引:11
作者
Guthke, R
Zeilinger, K
Sickinger, S
Schmidt-Heck, W
Buentemeyer, H
Iding, K
Lehmann, J
Pfaff, M
Pless, G
Gerlach, JC
机构
[1] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, D-07745 Jena, Germany
[2] Univ Med Berlin, Div Expt Surg, Surg Clin, D-13353 Berlin, Germany
[3] Univ Bielefeld, Tech Fac, Inst Cell Culture Technol, D-33615 Bielefeld, Germany
[4] BioControl Jena GmbH, D-07745 Jena, Germany
[5] Univ Pittsburgh, McGowan Inst Regenerat Med, Dept Surg & Bioengn, Pittsburgh, PA USA
关键词
systems biology; metabolic network; liver support; bioreactor;
D O I
10.1007/s00449-005-0040-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The kinetics of 18 amino acids, ammonia (NH3) and urea (UREA) in 18 liver cell bioreactor runs were analyzed and simulated by a two-compartment model consisting of a system of 42 differential equations. The model parameters, most of them representing enzymatic activities, were identified and their values discussed with respect to the different liver cell bioreactor performance levels. The nitrogen balance based model was used as a tool to quantify the variability of runs and to describe different kinetic patterns of the amino acid metabolism, in particular with respect to glutamate (GLU) and aspartate (ASP).
引用
收藏
页码:331 / 340
页数:10
相关论文
共 15 条
[1]  
BUENTEMEYER H, 2000, ENCY CELL TECHNOLOGY, P945
[2]   Characterization of the distribution of matter in hybrid liver support devices where cells are cultured in a 3-D membrane network or on flat substrata [J].
Catapano, G ;
Euler, M ;
Gaylor, JDS ;
Gerlach, J .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2001, 24 (02) :102-109
[3]  
GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.2307/2334381
[4]   METABOLIC ZONATION OF THE LIVER - REGULATION AND IMPLICATIONS FOR LIVER-FUNCTION [J].
GEBHARDT, R .
PHARMACOLOGY & THERAPEUTICS, 1992, 53 (03) :275-354
[5]   Experimental evaluation of a cell module for hybrid liver support [J].
Gerlach, JC ;
Botsch, M ;
Kardassis, D ;
Lemmens, P ;
Schön, M ;
Janke, J ;
Puhl, G ;
Unger, J ;
Kraemer, M ;
Busse, B ;
Böhmer, C ;
Belal, R ;
Ingenlath, M ;
Kosan, M ;
Kosan, B ;
Sültmann, J ;
Patzold, A ;
Tietze, S ;
Rossaint, R ;
Müller, C ;
Mönch, E ;
Sauer, IM ;
Neuhaus, P .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2001, 24 (11) :793-798
[6]   Is a clinical application of hybrid liver support systems limited by an initial disorder in cellular amino acid and alpha-keto acid metabolism, rather than by later gradual loss of primary hepatocyte function? [J].
Gerlach, JC ;
Fuchs, M ;
Smith, MD ;
Bornemann, R ;
Encke, J ;
Neuhaus, P ;
Riedel, E .
TRANSPLANTATION, 1996, 62 (02) :224-228
[7]   Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: A morphologic study. [J].
Gerlach, JC ;
Mutig, K ;
Sauer, IM ;
Schrade, P ;
Efimova, E ;
Mieder, T ;
Naumann, G ;
Grunwald, A ;
Piess, G ;
Mas, A ;
Bachmann, S ;
Neuhaus, P ;
Zeilinger, K .
TRANSPLANTATION, 2003, 76 (05) :781-786
[8]   COMPARISON OF 4 METHODS FOR MASS HEPATOCYTE ISOLATION FROM PIG AND HUMAN LIVERS [J].
GERLACH, JC ;
BROMBACHER, J ;
KLOPPEL, K ;
SCHNOY, N ;
NEUHAUS, P .
TRANSPLANTATION, 1994, 57 (09) :1318-1322
[9]  
KILBERG MS, 1980, J BIOL CHEM, V255, P4011
[10]  
PFAFF M, 2004, INTELLIGENT TECHNOLO, P57